{"slug":"pt-141-ibd","verification":{"valid":true,"entries":2,"head":"a2b2a868067baf7eca439b3979d3fdeee34152508b772bd2e95965177f4accb4"},"energy":{"passes":2,"tokens_in":23154,"tokens_out":2239,"tokens_total":25393,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"a2b2a868067baf7eca439b3979d3fdeee34152508b772bd2e95965177f4accb4"},"provenance":[{"ts":"2026-06-30T01:15:03.286Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Ibd\nSlug: pt-141-ibd\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"IBD (Crohn's / colitis)\",\"condition_key\":\"ibd-crohns-colitis\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have IBD (Crohn's / colitis)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have IBD (Crohn's / colitis)\",\"Why PT-141 might help you\",\"How these fit to","response":"{\"slug\":\"pt-141-ibd\",\"title\":\"PT-141 for IBD (Crohn's / Colitis): Evidence Review\",\"body\":\"## What's breaking down if you have IBD (Crohn's / colitis)\\n\\nIBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.\\n\\nLayers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.\\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.\\n\\n## How these fit together\\n\\nSingle-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tissue repair or inflammation modulation. PT-141 stands alone here because its documented actions center on arousal circuits rather than primary gut repair.\\n\\n## What the evidence actually shows\\n\\nNo human trials test PT-141 in IBD patients (human tier: absent). No rat or mouse studies administer PT-141 in colitis models (preclinical tier: absent for this peptide). A 2023 review examined the broader melanocortin system in IBD using mouse colitis models and noted potential anti-inflammatory roles for related peptides such as α-MSH and KPV (preclinical tier: melanocortin system in general). PT-141","tokens_in":23154,"tokens_out":2239,"cost":0,"prev":"genesis","hash":"9a072c08d00f2ee46d9e75a9f06bd1cfd02ffa4d6543c94e828da44590ff1fcc"},{"ts":"2026-07-17T02:41:06.983Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-ibd","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9a072c08d00f2ee46d9e75a9f06bd1cfd02ffa4d6543c94e828da44590ff1fcc","hash":"a2b2a868067baf7eca439b3979d3fdeee34152508b772bd2e95965177f4accb4"}]}